NCT03086460View on ClinicalTrials.gov

A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)

PHASE2CompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

September 8, 2017

Primary Completion Date

July 23, 2018

Study Completion Date

July 28, 2018

Conditions
Asthma
Interventions
DRUG

CHF 1531 pMDI

Dose Response: Test one of five different doses of CHF 1531

DRUG

Formoterol Inhalation Solution

Active Control

DRUG

Placebo pMDI

Matched Placebo

Trial Locations (10)

21093

Chiesi Investigational Site, Lutherville

27607

Chiesi Investigational Site, Raleigh

29118

Chiesi Investigational Site, Orangeburg

29303

Chiesi Investigational Site, Spartanburg

29615

Chiesi Investigational Site, Greenville

37909

Chiesi Investigational Site, Knoxville

63141

Chiesi Investigational Site, St Louis

85710

Chiesi Investigational Site, Tucson

90048

Chiesi Investigational Site, Los Angeles

99352

Chiesi Investigational Site, Richland

All Listed Sponsors
lead

Chiesi Farmaceutici S.p.A.

INDUSTRY

NCT03086460 - A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH) | Biotech Hunter | Biotech Hunter